Kalexobio
1 known investors
Kalexo Bio develops dual-targeting siRNA therapeutics for cardiovascular disease, with a focus on lipid management and atherosclerotic disease prevention. The company's lead program targets genetic drivers of cardiovascular risk to deliver durable risk reduction in patients.
BiotechDigital HealthMedical Devices